UNIVERSITY OF SYDNEY
THE UNIVERSITY OF SYDNEY, NSW 2006
$21.92M
Total Contract Value
20 awards
First Award
Aug 30, 2022
Last Award
Sep 18, 2025
Business Size
other than small
CAGE Code
ZE960
Top Industries (NAICS)
| NAICS Code | Obligations | Awards |
|---|---|---|
| 541715 | $10.96M | 7 |
| 541714 | $1.23M | 4 |
| 541690 | $687K | 2 |
Contract Awards
8 awards found
75N93022C00041
Department of Health and Human Services
$2.00M
Sep 18, 2025
ADVANCING VACCINE ADJUVANT RESEARCH FOR TUBERCULOSIS (TB) AND EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING
NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2025
75F40122C00202
Department of Health and Human Services
$245K
Aug 17, 2024
PMQWP 345/CDER-2022-113555 - IMPROVE SCIENTIFIC APPROACHES TO EVALUATE GENERIC DRUGS.
NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2024
75N93022C00041
Department of Health and Human Services
$2.89M
Aug 8, 2024
ADVANCING VACCINE ADJUVANT RESEARCH FOR TUBERCULOSIS
NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2024
75F40123C00201
Department of Health and Human Services
$687K
Sep 21, 2023
DEVELOPMENT OF A LASER-BASED TESTING PLATFORM FOR GENERIC DRY POWDER.
NAICS: 541690 - OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICESFY2023
75N93022C00041
Department of Health and Human Services
$3.62M
Aug 31, 2023
ADVANCING VACCINE ADJUVANT RESEARCH FOR TUBERCULOSIS
NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2023
75F40122C00202
Department of Health and Human Services
$225K
Aug 21, 2023
PMQWP 345/CDER-2022-113555 - IMPROVE SCIENTIFIC APPROACHES TO EVALUATE GENERIC DRUGS.
NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2023
75F40122C00202
Department of Health and Human Services
$764K
Sep 27, 2022
PMQWP 345/CDER-2022-113555 - IMPROVE SCIENTIFIC APPROACHES TO EVALUATE GENERIC DRUGS.
NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2022
75N93022C00041
Department of Health and Human Services
$2.45M
Aug 30, 2022
ADVANCING VACCINE ADJUVANT RESEARCH FOR TUBERCULOSIS
NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2022
Business Details
- UEI
- CRPQN9NU7X28
- CAGE Code
- ZE960
- Address
- LEVEL 3, ADMINISTRATION BUILDING F23
THE UNIVERSITY OF SYDNEY, 2006
Parent Company
UNIVERSITY OF SYDNEY
Data Source
This profile is based on federal contract award data from USAspending.gov.
View on USAspending.gov